← Back to Search

Behavioral Intervention

Caregiver Engagement Strategies for Youth Substance Abuse

N/A

Waitlist Available

Led By Phillippe Cunningham, Ph.D.

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 36 months

Awards & highlights

Study Summary

This trial will test if a prize-based system can increase caregiver engagement in drug court and treatment, which may lead to reduced substance use and delinquent behavior in youth.

Who is the study for?

This trial is for young people aged 13-17 who are involved in juvenile drug courts and willing to participate, along with at least one caregiver also willing to engage in the treatment. Participants must be fluent in English or Spanish.Check my eligibility

What is being tested?

The study is examining if adding a reward-based program (Caregiver Contingency Management) to the usual drug court treatment helps increase caregiver involvement and improves outcomes like reducing substance use and delinquent behavior among youth.See study design

What are the potential side effects?

Since this trial involves behavioral interventions rather than medications, traditional side effects are not applicable. However, participants may experience stress or discomfort related to changes in therapy or court processes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 36 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 36 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes from baseline to 18 months post-baseline in Youth Substance Use Frequency and Problems (measured at 0, 1, 2, 3, 4, 5, 6, 9, 12, and 18 months).

Changes from baseline to 18 months post-baseline in Youth Urine Drug Screens (measured at 0, 3, 5, 6, 9, 12, and 18 months).

Secondary outcome measures

Changes from Baseline to 18 months post-baseline in caregiver reports on Youth Internalizing Symptoms and Externalizing Behaviors (measured at 0, 1, 2, 3, 4, 5, 6, 9, 12, and 18 months).

Changes from Baseline to 18 months post-baseline in youth reports on Youth Internalizing Symptoms and Externalizing Behaviors (measured at 0, 1, 2, 3, 4, 5, 6, 9, 12, and 18 months).

Changes from baseline to 18 months post-baseline in Youth Arrests, Charges, and Convictions.

+12 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Caregiver Contingency Management + Usual Drug Court TreatmentExperimental Treatment1 Intervention

This group will receive a caregiver contingency management intervention plus the standard outpatient substance abuse treatment services provided at JDC.

Group II: Usual Drug Court TreatmentActive Control1 Intervention

This group will receive the standard outpatient substance abuse treatment services provided at JDC.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Caregiver Contingency Management + Usual Drug Court Treatment

2017

N/A

~200

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Baylor UniversityOTHER

55 Previous Clinical Trials

64,957 Total Patients Enrolled

Medical University of South CarolinaLead Sponsor

932 Previous Clinical Trials

7,394,065 Total Patients Enrolled

4 Trials studying Substance Abuse

979 Patients Enrolled for Substance Abuse

National Institute on Minority Health and Health Disparities (NIMHD)NIH

380 Previous Clinical Trials

1,215,459 Total Patients Enrolled

1 Trials studying Substance Abuse

244 Patients Enrolled for Substance Abuse

Media Library

Caregiver Contingency Management + Usual Drug Court Treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03051997 — N/A

Substance Abuse Research Study Groups: Caregiver Contingency Management + Usual Drug Court Treatment, Usual Drug Court Treatment

Substance Abuse Clinical Trial 2023: Caregiver Contingency Management + Usual Drug Court Treatment Highlights & Side Effects. Trial Name: NCT03051997 — N/A

Caregiver Contingency Management + Usual Drug Court Treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03051997 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available opportunities for participants in this clinical trial?

"Clinicaltrials.gov displays that this medical experiment, initially posted on October 13th 2017 is not presently inviting patients to join. Nonetheless, 362 other clinical trials are currently open for enrollment."

Answered by AI

What outcomes are researchers hoping to attain with this trial?

"This trial, which is evaluated from outset to 18 months post-baseline, aims to analyse the frequency and severity of substance use in youth as well as caregiver attendance at their treatment sessions. Secondary objectives involve assessing rates of completion for the therapy program, as well as changes observed in caregivers' addiction problems (measured on the Addiction Severity Index)."

Answered by AI

What are the eligibility criteria for partaking in this clinical investigation?

"This research requires 195 volunteers who are between 13 and 89 years old and have a history of substance abuse. Additionally, the chosen participants must meet additional standards such as being involved in juvenile drug court, being willing to take part, and having at least one caregiver's consent for their involvement with this trial."

Answered by AI